| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 263.746 | 183.804 | 417.122 | 0 | 170.586 | 84.751 | 86.410 | 84.330 | 63.056 | 30.828 |
| Total Income - EUR | 266.684 | 184.461 | 419.359 | 0 | 173.564 | 84.827 | 86.909 | 105.131 | 63.154 | 31.553 |
| Total Expenses - EUR | 264.415 | 235.876 | 275.889 | 0 | 223.479 | 120.983 | 96.884 | 93.406 | 71.221 | 17.183 |
| Gross Profit/Loss - EUR | 2.270 | -51.414 | 143.469 | 0 | -49.915 | -36.156 | -9.976 | 11.726 | -8.067 | 14.370 |
| Net Profit/Loss - EUR | 1.036 | -51.414 | 138.191 | 0 | -51.654 | -37.007 | -10.831 | 10.698 | -8.685 | 14.060 |
| Employees | 10 | 12 | 15 | 0 | 9 | 5 | 3 | 4 | 4 | 1 |
Check the financial reports for the company - Dermavaprest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 115.071 | 138.804 | 102.896 | 0 | 81.832 | 73.890 | 67.821 | 66.406 | 65.159 | 64.381 |
| Current Assets | 167.874 | 129.148 | 345.950 | 0 | 323.361 | 225.370 | 188.309 | 158.182 | 177.744 | 203.016 |
| Inventories | 541 | 9.642 | 3.084 | 0 | 6.563 | 5.152 | 4.838 | 24.305 | 23.489 | 23.358 |
| Receivables | 163.302 | 113.179 | 334.180 | 0 | 313.019 | 206.551 | 176.646 | 130.063 | 140.903 | 165.660 |
| Cash | 4.031 | 6.327 | 8.686 | 0 | 3.778 | 13.666 | 6.825 | 3.814 | 13.351 | 13.997 |
| Shareholders Funds | 78.869 | 24.555 | 162.330 | 0 | 205.082 | 164.187 | 141.062 | 144.946 | 135.821 | 149.122 |
| Social Capital | 45 | 45 | 44 | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 204.077 | 243.397 | 286.515 | 0 | 200.354 | 135.591 | 115.213 | 79.767 | 107.082 | 118.274 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Dermavaprest Srl